MTOR and autosomal dominant polycystic kidney disease: In addition, although several preclinical and clinical trials have reported that rapamycin has a beneficial effect on ADPKD 25, 26, no direct link between polycystin dysfunction and mTOR signalling changes or ADPKD cystogenesis has been established.